Program
Day 3 (May 9, Sat)
07:30-08:30
Meet the Expert Ⅰ
07:30-08:30
Exacerbations of Asthma and COPD: Future Prospects
Sebastian Johnston (UK)
08:30-09:00
Break
07:30-08:30
Meet the Expert Ⅱ
07:30-08:30
How High is Too High: a Case-based Approach
Amy Klion (USA)
08:30-09:00
Break
07:30-08:30
Meet the Expert Ⅲ
07:30-08:30
Translating Basic Science to Clinical Impact in Chronic Cough
Stuart Mazzone (Australia)
08:30-09:00
Break
07:30-08:30
Meet the Expert Ⅳ
07:30-08:30
Monitoring Asthma in Children in Real Life
Nikolaos G. Papadopoulos (Greece)
08:30-09:00
Break
09:00-09:40
Plenary Lecture Ⅴ
Jung Won Park (Korea), Woo-Jung Song (Korea)
09:00-09:40
Delabeling Drug Allergy: A Global Strategy for Antimicrobial Stewardship and Patient Safety
Ingrid Terreehorst (Netherlands)
09:40-10:20
Plenary Lecture Ⅵ
Jung Won Park (Korea), Woo-Jung Song (Korea)
09:40-10:20
Central Mechanisms of Chronic Cough Hypersensitivity
Stuart Mazzone (Australia)
10:20-10:40
Break
13:50-14:30
Plenary Lecture Ⅶ
Minsuk Yang (Korea)
13:50-14:30
Precision Medicine for HES: From Phenotype to Genotype
Amy Klion (USA)
10:40-12:10
Oral Presentation Ⅳ
Yong Won Lee (Korea), Hyo Bin Kim (Korea)
10:40-10:50
Cigarette smoke induces the pro-inflammatory response of lung macrophages via the IL-33–ST2-dependent pathway promoting Th17 immune responses
Yosep Mo (Korea)
10:50-11:00
Impact of Long-Term Air Pollution Exposure on Asthma and Allergy Incidence in Delhi: A Population-Based Cohort Study
Chandan - (India)
11:00-11:10
Mathematical Modeling of Wildfire Smoke Shock Propagation and Delayed Asthma Mortality Pressure Using Satellite Fire Detection, Atmospheric Reanalysis, and Population-Level Mortality Data
Prihantini Prihantini (Indonesia)
11:10-11:20
Psychological stress impairs PD-L2+ macrophage efferocytosis via Adrb2 and exacerbates IgE-mediated skin inflammation
Soichiro YOSHIKAWA (Japan)
11:20-11:30
Clinical characteristics, triggers, and management of anaphylaxis in the emergency department: a 5-year retrospective analysis at the First Central Hospital of Mongolia (FCHM)
Dalai Bayarsaikhan (Mongolia)
11:30-11:40
Factors associated with serious outcomes among patients with Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis seen at a tertiary hospital in the Philippines
Alhana Ayaon (Philippines)
11:40-11:50
Low-dose, slow-escalation home based oral immunotherapy for walnut and cashew allergy: a retrospective case series
Kouhei Hagino (Japan)
11:50-12:00
Latent Helminth Exposure Reshapes Vaccine-Linked Allergic Immune Trajectories in Children After Routine Vaccination Through IL-10 Dominance, Regulatory T-Cell Expansion, and Blunted IgE Sensitization Across Under-Resourced Tropical Districts
Irish Alvarez (Philippines)
12:00-12:10
Development of a T Cell-Mediated Allergic Skin Inflammation Model Using an Activated Jurkat Cell Co-Culture System
Yeonji Park (Korea)
12:10-12:20
Break
12:20-13:00
Sponsored Symposium X (Novartis Korea)
Young-Min Ye (Korea)
12:20-13:00
BTK Inhibitor in CU: Clinical Outcomes and Lessons from Early Real-World Use
Sarbjit Singh Saini (USA)
13:00-13:50
Break & Poster Discussion Ⅱ
14:50-16:20
KAAACI-Interasma Symposium Ⅱ. Severe Asthma Linking Endotypes to Airway Remodeling
Dae Hyun Lim (Korea), Sebastian Johnston (UK)
14:50-15:20
Optimal Diagnosis and Management of ABPA/ABPM in the Biologics Era
Koichiro Asano (Japan)
15:20-15:50
Translating Severe Asthma Endotypes for Clinical Insight: Epithelial Dysfunction, Upstream Targets, and Airway Remodeling
So Ri Kim (Korea)
15:50-16:20
Airway and Vascular Remodeling: Inspiratory–expiratory CT Changes in Severe Asthma
Sanghun Choi (Korea)
10:40-12:10
Oral Presentation Ⅴ
Dong In Suh (Korea), Ji-Yong Moon (Korea)
10:40-10:50
Maternal dietary trajectories from preconception to late pregnancy among mothers with and without comorbidities and their association with offspring atopic outcomes: Findings from the S-PRESTO cohort
Aisyah Faisal (Singapore)
10:50-11:00
Clustering of longitudinal egg white-specific IgE trajectories and analysis of specific IgE dynamics following egg oral immunotherapy
Harrin Kim (Korea)
11:00-11:10
Early-life exposure to environmental paraben and phenol is associated with AD severity and persistence in children
SANGHEE SHIN (Korea)
11:10-11:20
Epithelial fucosylation drives airway barrier dysfunction and allergic inflammation via a FUT1-CDH12 axis
Wenjing Gu (China)
11:20-11:30
Hidden by pooling: Simpson’s paradox in associations between FeNO and cough outcomes in chronic cough
Kyung Eun Park (Korea)
11:30-11:40
Early treatment response as a predictor of long-term outcomes in chronic cough
Eun-Jung Jo (Korea)
11:40-11:50
Long-term effectiveness of tiotropium on chronic cough and capsaicin cough reflex sensitivity in asthma
Kensuke Fukumitsu (Japan)
11:50-12:00
Altered central neural activity in patients with gastroesophageal reflux-related cough: A resting-state fMRI study
Shuxin Zhong (China)
12:00-12:10
Rise in perioperative chlorhexidine-associated anaphylaxis after the COVID-19 pandemic
Pui Hei Marcus Man (Hong Kong)
12:10-12:20
Break
12:20-13:00
Sponsored Symposium XI (AstraZeneca Korea)
You Sook Cho (Korea)
12:20-13:00
Precision Medicine in Severe Eosinophilic Asthma: Role of Benralizumab
Guy Brusselle (Belgium)
13:00-13:50
Break & Poster Discussion Ⅱ
14:50-16:20
Working Group Symposium Ⅱ. Hypersensitivity to Cancer Therapies and Biologic Agents
Youngkoo Jee (Korea), Hye Ryun Kang (Korea)
14:50-15:20
Immune Checkpoint Inhibitors: Hypersensitivity vs Immune-mediated Adverse Events
Riichiro Abe (Japan)
15:20-15:50
Hypersensitivity to Biologic Therapies in Allergic and Immune-mediated diseases
Da Woon Sim (Korea)
15:50-16:20
Real World Outcomes of Dsensitization to Anticancer Agents and Biologic Therapies
Young Chan Kim (Korea)
10:40-12:10
Oral Presentation Ⅵ
Bong Seong Kim (Korea), So Ri Kim (Korea)
10:40-10:50
Clinical efficacy of low-power LED (Light Emitting Diode), light irradiator in allergic rhinitis patients
Seon Tae Kim (Korea)
10:50-11:00
Surveys on Real-World Practice Patterns in the Pharmacological Treatment of Allergic Rhinitis
MIAE KIM (Korea)
11:00-11:10
Long-term clinical and inflammatory outcomes of elderly versus non-elderly asthma: a five-year cohort study
Youngsoo Lee (Korea)
11:10-11:20
Parallel Trajectories of Lung Function and Allergic Sensitization in Childhood Asthma: A 7-Year Prospective Study
Jisun Yoon (Korea)
11:20-11:30
Clinical Remission in Chronic Cough: A 3-Year Prospective Cohort Study
Hwa Young Lee (Korea)
11:30-11:40
Clinical characteristics and treatment patterns of allergic bronchopulmonary aspergillosis at a Korean tertiary asthma care center
Hyun Kyung Oh (Korea)
11:40-11:50
Bridging the Gap in Biologic Therapy Decision-Making: A Cross-Sectional Survey of Patients and Clinicians with Severe Asthma
Jiung Jeong (Korea)
11:50-12:00
Consensus on the criteria for defining the minimal clinically important difference in adults with severe asthma receiving biologic therapy: A Modified Delphi Study
Hyo In Rhyou (Korea)
12:00-12:10
Patient-perceived asthma control may not adequately reflect clinical outcomes in severe asthma: a longitudinal analysis from the KoSAR
Kyung Eun Park (Korea)
12:10-12:20
Break
12:20-13:00
Sponsored Symposium XII (Celltrion Pharm)
Yoo Seob Shin (Korea)
12:20-13:00
Definition and Characteristics of Biosimilar, Clinical Use Experience
Sun Young Paik (Korea)
13:00-13:50
Break & Poster Discussion Ⅱ
14:50-16:20
Symposium Ⅵ. Integrating National Research and Registry Data to Advance Asthma Care Across the Lifespan
Won Ho Kim (Korea), Sang Heon Kim (Korea)
14:50-15:20
KoSAR: Current Status and Real-world Evidence to Improve Severe Asthma Management
Heung-Woo Park (Korea)
15:20-15:50
Korean Childhood Asthma Study (KAS): Phenotypes and Remission in Children with Asthma
Hyeon Jong Yang (Korea)
15:50-16:05
National Research Programs in Respiratory and Allergic Diseases at the Korea NIH: Current Projects and Strategic Directions
Young Youl Kim (Korea)
16:05-16:20
National Atopic Dermatitis and Asthma Prevention and Management Program at the Korea Disease Control and Prevention Agency
Yeon-Kyeng Lee (Korea)
10:40-12:10
Oral Presentation Ⅶ
Jae-Woo Kwon (Korea), You Hoon Jeon (Korea)
10:40-10:50
Basophil Activation Test as a Biomarker for Clinical Severity in Iodinated Contrast Media Hypersensitivity
Sejin Park (Korea)
10:50-11:00
To switch or not to switch? The “catch-up” phenomenon and long-term outcomes of slow responders to dupilumab in atopic dermatitis
Ji Hyun OH (Korea)
11:00-11:10
Implementation of a Programmable Infusion Pump for One-Bag Chemotherapy Desensitization: Safety and Outcomes from a Nationwide Multicenter Registry
Jiyeon Park (Korea)
11:10-11:20
Development of a hypoallergenic Jug r 1 variant for Immunotherapy in children with walnut allergy
Jeongmin Lee (Korea)
11:20-11:30
Effect of 1-Kestose supplementation on the safety and efficacy of oral immunotherapy in children with food allergies
MINYOUNG JUNG (Korea)
11:30-11:40
Multicenter Analysis of Food Protein-Induced Enterocolitis Syndrome Presentations in Young Children Presenting with delayed vomiting
Kyunguk Jeong (Korea)
11:40-11:50
Diagnostic utility of soybean-specific IgE for risk stratification of soybean-sensitized Korean children
Yusin Kim (Korea)
11:50-12:00
From Monogenic to Pathway-Based Interpretation: Expanding the Genetic Landscape of Hereditary Angioedema Using Whole-Exome Sequencing
Young-Chan Kim (Korea)
12:00-12:10
Long-term Clinical Outcome of Chronic Spontaneous Urticaria: Real-World Evidence
Hyun-Seob Jeon (Korea)
12:10-12:20
Break
13:00-13:50
Break & Poster Discussion Ⅱ
16:20-16:30
KAAACI Award Ceremony & Closing